ATLANTA, Oct. 28, 2016 /PRNewswire/ -- Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, recently secured approval for a sugar-free bioequivalent to the antihistamine/decongestant Bromfed DM® Cough Syrup (brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup, 2mg/30mg/10mg per 5mL).* This combination of pharmaceutical ingredients is used to temporarily relieve the symptoms caused by the common cold, flu, allergies, and other breathing illnesses. This latest approval expands Acella’s already diverse portfolio of products and underscores the its commitment to effective and affordable health care solutions for its customers.
“We view Acella as an important niche company that works diligently to provide purposeful healthcare solutions, with value at the forefront of our corporate mission,” said Acella CEO Art Deas. “This latest approval of a sugar-free, bioequivalent to Bromfed DM® Cough Syrup is timely as we enter cough-cold season, when patients are most in need of cost-effective options.”
“Having a sugar-free, bioequivalent to Bromfed DM® Cough Syrup supports our strategy of providing pharmaceutical drugs to all of our customers,” said Allen Fields, Acella Senior VP, Clinical and Regulatory Affairs, Head of Research and Development. “We are excited about our other, affordable products currently under review with the U.S. Food and Drug Administration, in fulfilment of our mission to patients and managed care.”
* Except for Acella’s product, all other product names, logos, trademarks, and brands referenced in this material are the property of their respective owners, and for identification purposes only. Except as expressly stated, the use of any other product name, logo, trademark or brand does not mean or imply association with, or endorsement by the holder of, that other product name, logo, trademark or brand.
About Acella Pharmaceuticals, LLC
Founded in 2007, Acella Pharmaceuticals is a specialty pharmaceutical company committed to accelerating the health care solution by bringing quality, affordable products to customers and patients. Acella develops, markets, sells and distributes a broad portfolio of non-branded pharmaceutical products in the areas of Dermatology, Women’s Health, Pediatrics and other applications. For additional information please contact Acella at 678-325-5189 or visit www.acellapharma.com.
Logo - http://photos.prnewswire.com/prnh/20160407/352847LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/acella-pharmaceuticals-llc-announces-approval-of-a-generic-bromfed-antihistaminedecongestant-300353336.html
SOURCE Acella Pharmaceuticals, LLC
